VIENNA, Va., Aug. 08, 2025 (GLOBE NEWSWIRE) — USX Cyber(R), a leading innovator in cybersecurity and compliance automation, proudly announces the release of its new in-house Application Control module–a powerful enhancement to its flagship GUARDIENT(R) platform. Built for both end-user simplicity and enterprise-grade remote management, the new feature redefines how organizations control what runs on […]

USX Cyber(R) Launches Integrated Application Control Module in GUARDIENT(R) Platform GlobeNewswire August 08, 2025 VIENNA, Va., Aug. 08, 2025 (GLOBE NEWSWIRE) — USX Cyber(R), a leading innovator in cybersecurity and compliance automation, proudly announces the release of its new in-house Application Control module–a powerful enhancement to its flagship GUARDIENT(R) platform. Built for both end-user simplicity

First Horizon Corporation (NYSE: FHN or “First Horizon”)is proud to announce that Senior Executive Vice President and Chief Financial Officer Hope Dmuchowski has been named to theMemphis Business Journal's Super Women in Business Class of 2025. https://mma.prnewswire.com/media/2747044/First_Horizon_Hope_Dmuchowski_2025.jpg This honor celebrates high-achieving women in the Memphis business community who have made significant contributions in their fields

(TSX:SAP), MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company) announces that the nominees listed in the management information circular dated June 5, 2025, were elected as directors of Saputo at the annual meeting of shareholders held on August 8, 2025. Each of the following ten nominees proposed by

Saputo Announces Election of Directors GlobeNewswire August 08, 2025 MONTRÉAL, Aug. 08, 2025 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company) announces that the nominees listed in the management information circular dated June 5, 2025, were elected as directors of Saputo at the annual meeting of shareholders held on August 8, 2025.

This press release is not intended for UK media. HERNEXEOS(R) (zongertinib tablets) approved based on an objective response rate of 75% (N=71), as demonstrated in the Beamion-LUNG 1 clinical trial1 Accelerated approval follows Priority Review and Breakthrough Therapy Designation granted by the U.S. FDA for the treatment of patients with HER2 (ERBB2)-mutant advanced non-small cell

U.S. FDA grants accelerated approval to Boehringer's HERNEXEOS(R) as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC GlobeNewswire August 08, 2025 This press release is not intended for UK media. HERNEXEOS(R) (zongertinib tablets) approved based on an objective response rate of 75% (N=71), as demonstrated in the Beamion-LUNG 1 clinical

Phoenix, AZ – My Chiropractor Health and Wellness Center continues to set the standard in holistic health by offering advanced integrative therapies tailored to enhance recovery and wellness for patients throughout Arizona. With established cutting-edge treatments like Theta Therapy, Shockwave Therapy, and Cranial Facial Therapy, among other drug-free modalities, the center has become a trusted

The countdown is on! In just 15 days, the Pacific Pride Festival returns to Chase Palm Park Field on Saturday, August 23rd from 11AM-7PM, marking 50 years of Pride on the Central Coast. https://mma.prnewswire.com/media/2747067/Pacific_Pride_Foundation_Logo.jpg This year's theme, “Rooted in Pride: Embracing Our Past – Empowering Our Future,” honors the resilience and joy of the LGBTQ+

NEW YORK, NY / ACCESS Newswire / August 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Marex Group plc ("Marex" or "the Company") (NASDAQ:MRX). Investors who purchased Marex securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/MRX. Investigation